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The ethnic profile of patients with birthmarks
reveals interaction of germline and postzygotic
genetics
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DEAR EDITOR, GNA11 and GNAQ are highly homologous genes
encoding different Ga subunits of heterotrimeric G-proteins.
We recently described postzygotic activating mutations in
GNA11 or GNAQ as causes of phakomatosis pigmentovascularis
(PPV), and GNAQ mosaicism as a cause of extensive dermal
melanocytosis (EDM).1 GNAQ mosaicism has previously been
found to cause Sturge–Weber syndrome (SWS) and isolated
nonsyndromic port-wine stain-type capillary malformations.2
In all of these clinical phenotypes the mutations almost exclu-
sively affect codons 183 of the protein products Gaq and Ga11.
What is not yet understood is how the same mutations can
lead to such differing skin phenotypes, either vascular alone
(SWS), pigmentary alone (EDM) or a combination of both
(PPV). The existence of a common precursor cell leading to
both the vascular and pigmentary birthmarks is likely, as the
same mutation has been identified in both types of lesion in
patients with PPV. In mosaic disorders we would usually
therefore invoke the issue of the timing of the mutation as the
cause of differing phenotypes, or in other words that the
mutation leading to PPV would be expected to occur earlier in
embryogenesis than that for SWS or EDM. If this were the case
we would expect the multiorgan phenotype in PPV to be
more severe than in SWS, owing to an earlier embryological
mutation. This was suggested in one case series of PPV;3 how-
ever, owing to the well-known phenomenon of dermal
melanocytosis being overlooked as a normal finding by exam-
ining doctors,4 it is likely that PPV is currently underdiag-
nosed in comparison with SWS, and publications relating to
PPV may therefore be biased towards severe cases. Even if tim-
ing of the mutation proves to be important once larger
cohorts are collected, germline genetic factors could also con-
tribute to the differences in phenotype observed from the
same mutations.
Looking at our patient cohorts we hypothesized that ethnic-
ity may be associated with a phenotype-modifying effect in
this spectrum of diseases. Although ethnicity is a loosely
defined classification, it is already known to be clearly associ-
ated with self-resolving dermal melanocytosis (Mongolian blue
spots), which is far more common in Afro-Caribbean than
white populations.4 A bias towards nonwhite ethnicity was
suggested in one previous study of PPV,3 but it was not sys-
tematically studied against control populations.
Ethnicity data are collected routinely upon attendance at our
hospital, where patients and families choose their own
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Fig 1. Cutaneous phenotypic spectrum of mosaic G-protein disorders. Patients with identical mosaic mutations in GNAQ (codon 183), presenting
phenotypically with (a) Sturge–Weber syndrome, (b) phakomatosis pigmentovascularis and (c) extensive dermal melanocytosis.
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ethnicity from a standard list. We have assumed that there
should be no inherent bias in this choice relating to the type
of birthmark with which the child presents. Ethnicity data
were extracted for all patients seen in our department over a
2-year period, between March 2011 and March 2013, with a
diagnosis of SWS, isolated facial port-wine stain, congenital
melanocytic naevi, congenital epidermal naevi and infantile
haemangioma. For the rarer conditions PPV and EDM, where
patient numbers were small, we obtained information relating
to all patients with the condition rather than restricting our
observations to this time period, to maximize the size of this
cohort.
A review of the clinical records was used to complete miss-
ing data where possible. To ensure that the common occur-
rence of self-resolving Mongolian blue spots did not bias our
data collection, dermal melanocytosis was considered to be
relevant only where it was ‘atypical’. On the basis of observa-
tional studies of normal Mongolian blue spots4,5 we have
defined this as fulfilling any two of the following criteria: (i)
involvement of sites other than only the lumbosacral area, (ii)
persistence beyond the first 2 years of life, (iii) areas > 10 cm
in diameter at birth and (iv) some areas of accentuated deep
pigmentation with clearly defined borders. Examples of the
clinical phenotypes for PPV and EDM are shown in Figure 1.
(a)
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Fig 2. (a) Ethnicity of patients with different birthmarks attending Great Ormond Street Hospital paediatric dermatology department. CMN,
congenital melanocytic naevus; PWS, isolated port-wine stain; SWS, Sturge–Weber syndrome; EDM, extensive dermal melanocytosis; PPV,
phakomatosis pigmentovascularis. Patients who self-reported in the ‘other’ ethnicity cohort were predominantly of Middle Eastern descent. This is
not currently offered as an ethnic category in our hospital’s admission documentation, which uses standardized National Health Service ethnic
category codes derived from the classification used by the Office of National Statistics for the 2001 census. (b) Ethnicity profile of different
birthmarks comparing white vs. nonwhite ethnicity. *P < 0001 using Fisher’s exact test.
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The percentages of different ethnicities in our whole referral
cohort revealed a substantial preponderance of white ethnicity
in all birthmark groups, as would be expected for our geo-
graphical referral population, except for PPV and EDM
(Fig. 2a). In these birthmark groupings there were signifi-
cantly fewer white patients; there were none in the EDM
cohort and only three out of 18 in the PPV cohort. Although
the numbers in these groups are relatively low, they are com-
parable with the numbers of nonwhite patients in all other
birthmark groupings. Furthermore, statistical comparison of
PPV or EDM and all other birthmark groupings revealed a sig-
nificant difference in white vs. nonwhite ethnicity (P < 0001,
Fig. 2b). When only the port-wine stain, SWS, PPV or EDM
birthmarks were analysed (restricting the analysis to these, as
we know they can be caused by GNAQ or GNA11 mosaicism)
the same pattern is in evidence; logistic regression modelling
of having a pigmentary component to the cutaneous pheno-
type produced an odds ratio for white ethnicity of 0017
(95% confidence interval 0005–0060, P < 0001). There was
no effect of sex.
The mechanism of this association between cutaneous phe-
notype within this diagnostic spectrum and ethnicity is not
yet clear. However, we hypothesize that germline ethnicity-
associated variants in pigment genes could be involved, per-
haps including the melanocortin-1 receptor gene MC1R, which
encodes a G-protein-coupled receptor. Variants in MC1R are
already known to modify the phenotype of congenital pig-
mentary disorders such as oculocutaneous albinism and con-
genital melanocytic naevi.6,7 Furthermore, although the
canonical signalling pathway from MC1R is via cyclic AMP,
there is some evidence that signalling via calcium release can
occur,8,9 which could support this hypothesis of coupling of
MC1R to Gaq and Ga11.
In conclusion, postzygotic mosaicism for GNA11 and GNAQ
mutations causes an overlapping phenotypic spectrum of vascu-
lar and melanocytic birthmarks, with associated ophthalmologi-
cal, neurological, overgrowth and malignant complications.
Ethnicity appears to be associated with congenital phenotypic
variation in the cutaneous component of this spectrum of
mosaic disease.
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